The email below was sent to Philips’ CPAP users on October 15, 2022 We are pleased to share an important update regarding your Philips device replacement. Philips received authorization from the US Food and Drug Administration (FDA) for the repair and replacement program for devices impacted by the June 14, […]
ARTICLES
Circadiance Added to SleepGlad AI Mask Fitter Formulary
Circadiance’s SleepWeaver masks are now on the SleepGlad formulary, a mask selection tool driven by artificial intelligence to help PAP patients find the perfect fit on the first try. This partnership puts Circadiance’s SleepWeaver PAP masks onto the SleepGlad mask formulary. SleepGlad is the world’s first remote, 3D-scanning PAP/NIV mask fitter, requiring no […]
eXciteOSA Daytime Sleep Apnea Therapy Device Surpasses 50,000 Patient Session Milestone
Signifier Medical Technologies Ltd, has announced it has hit the 50,000 therapy session milestone with its innovative eXciteOSA® sleep device. Following FDA authorization and clearance for marketing in February 2021, eXciteOSA has been quickly adopted by physicians and patients alike. The first of its kind, eXciteOSA is a daytime treatment for snoring and mild obstructive […]
Iconic Ambu Bag Turns 65
Ambu Inc. is celebrating the 65th birthday of its iconic invention, the Ambu Bag, the ubiquitous, lifesaving tool that has helped more than 45 million people breathe in the last 10 years alone. The Ambu Bag has come to define the self-inflating manual resuscitation device that is part of the standard […]
E-Cigarettes a Harm Reduction Tool? ATS Doesn’t Think So
“The ATS reiterates our long-held position – e-cigarettes are not “safe” and the claims that e-cigarettes are a harm reduction tool remain unproven. All e-cigarettes have significant health risks including nicotine addiction and respiratory disease,” said ATS President Lynn Schnapp, MD, ATSF. The ATS notes that the FDA has finally issued decisions […]
Investigational Sleep Apnea Pill Continues to Show Meaningful Benefit
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, today announced positive data across multiple endpoints from a Phase 2 randomized, double-blind, placebo-controlled, four-period, single-dose crossover factorial clinical trial (APC-003), and a 28-day open-label extension study, evaluating AD109 as […]
Dräger’s New Savina 300 NIV Offers Safe NIV Throughout the Care Continuum
To meet the need for safe, effective and reliable non-invasive ventilation (NIV) throughout the care continuum, Dräger has launched the new Savina 300 NIV, the latest ventilator in its Savina 300 family of ventilators. Built to Dräger’s exceptionally high standards and backed by its 100+ years of experience in mechanical ventilation, […]
Nox Medical Introduces Nox A1s PSG System
Nox Medical, the sleep technology arm of Nox Health, has released the Nox A1s PSG system which features hospital-to-home flexibility and product enhancements to its predecessor, Nox A1. The Nox A1s is a future-proof investment with telehealth capabilities to perform in-lab and at-home sleep testing, making it one of the […]
ACHC Launches Redesigned Website
ResMed Acquires HSAT Maker Ectosense
ResMed has completed the acquisition of Ectosense, a leader in cloud-connected home sleep test (HST) devices that can help millions of people with undiagnosed sleep apnea get the treatment they need – and raise general awareness of the disease. Ectosense’s FDA-approved NightOwl™ is sold in the United States, Australia, New […]













